Cell Therapy For Atrophic AMD Well Tolerated When Delivered Safely

MIAMI — Cell therapy with CNTO 2476, an adult stem cell treatment for atrophic age-related macular degeneration, is well tolerated when delivered safely into the subretinal space, a speaker told colleagues at Angiogenesis, Exudation, and Degeneration 2015.

Of the 35 subjects with bilateral geographic atrophy enrolled in the study, 33 received the cells via microcatheter.

“In this study, we need to do a better job with surgical delivery,” Allen C. Ho, MD, said, considering there was a 15% rate of retinal detachment with the method used. No patient had immune response, endophthalmitis, uveitis or tumor formation, however.

Ho gave early efficacy results on visual acuity accrued in the phase 1/2a clinical trial, but “with caution,” because the trial was small, unmasked and not controlled.

Mean visual acuity over 1 year in treated eyes improved four to five letters, whereas fellow eyes that were untreated lost approximately two letters, according to the presentation.

About 25% of treated eyes gained three lines of vision or more in best corrected visual acuity over 1 year, whereas no untreated eyes improved by that measure.

The strategy for therapy in this trial and in future trials of this cell line is to harvest adult umbilical tissue-derived cells without differentiation and to inject them subretinally to support or repair the diseased cells with cytokines or cell-to-cell interaction, according to the presentation.

“All the cells for this trial and the future trials will be derived from a single umbilical cord,” Ho said, with the cells being expanded according to good tissue practices, quality tested and cryopreserved into aliquots for delivery into the study subject’s eye.

A phase 2b randomized controlled trial is planned to begin in 2016, with an enrollment goal of 160 patients, Ho said – by Patricia Nale, ELS

Source by : http://goo.gl/e23o5u

Comments

Lab-Grown Blood Stem Cells Produced at Last

After 20 years of trying, scientists have transformed mature cells into primordial blood cells that regenerate themselves and the components of blood. The work, described today in Nature, offers hope to people with leukaemia and other blood disorders who need bone-marrow transplants but can’t find a compatible donor. If the findings translate into the clinic, these patients could receive lab-grown versions of their own healthy cells. One team, led by stem-cell biologist George Daley of Boston Children’s Hospital in Massachusetts, created human cells that act like blood stem cells, although they are not identical to those found in nature. A second team, led by stem-cell biologist Shahin Rafii of Weill Cornell Medical College in New York City, turned mature cells from mice into fully fledged blood stem cells. “For many years, people have figured out parts of this recipe, but they’ve never quite gotten there,” says Mick Bhatia, a stem-cell researcher at McMaster University i...

Mesentery: New organ discovered inside human body by scientists

A new organ has been discovered hiding in plain sight inside the human body . Known as the mesentery, it was previously thought to be just a few fragmented structures in the digestive system. But scientists have realised it is in fact one, continuous organ. Although its function is still unclear, the discovery opens up “a whole new area of science,” according to J Calvin Coffey, a researcher at the University Hospital Limerick who first discovered it. "When we approach it like every other organ… we can categorise abdominal disease in terms of this organ," he said. “Now we have established anatomy and the structure. The next step is the function. If you understand the function you can identify abnormal function, and then you have disease. “Put them all together and you have the field of mesenteric science.” The research has been published in The Lancet medical journa...

Stem Cell Therapy for Liver Cirrhosis

Stem Cell Therapy for Liver Cirrhosis Stem cell therapy is a promising area of research for the treatment of liver cirrhosis. Liver cirrhosis is a progressive condition in which the liver becomes scarred and damaged, leading to a loss of liver function. This can be caused by a variety of factors, including chronic alcohol abuse, viral hepatitis, and non-alcoholic fatty liver disease. Stem cells have the potential to regenerate damaged tissues and organs, including the liver. In the case of liver cirrhosis, stem cells can differentiate into liver cells and promote the growth of healthy tissue, thereby restoring liver function. Web: https://www.giostar.com/Therapy/liver-diseases/ Email: stemcells@giostar.com GIOSTAR Ahmedabad: +91-7043008890 GIOSTAR Bangalore: +91-6366209990 GIOSTAR Chandigarh: +91-9501768105 #STEM #stemcells #therapy #liver #cirrhosis #giostar #livercirrhosis #liverdisease #giostarindia

Stem Cells Therapy in India

Search This Blog